References

  1. Raharisolo Vololonantenaina CR, Rabarijaona LP, Rajemiarimoelisoa C, Rasendramino M, Migliani R. Bilan des cancers du sein diagnostiqués à l'Institut Pasteur de Madagascar de 1995 à 2001. Arch Inst Pasteur de Madagascar. 2003 ; 68 (1&2) : 82-86. PubMed | Google Scholar

  2. Rafaramino F, Rakotobe P, Pignon T. Prise en charge du cancer du sein à Madagascar. Cancer/Radiother. 2001; 5: 445-451. PubMed | Google Scholar

  3. Li CI, Daling JR, and Malone KE. Incidence of Invasive Breast Cancer by Hormone Receptor Status from 1992 to 1998. J Clin Oncol. 2003; (21): 28-34. PubMed | Google Scholar

  4. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS and Moorman PG. Hormone-related Factors and Risk of Breast Cancer in Relation to Estrogen Receptor and Progesterone Receptor Status. American Journal of Epidemiology. 2000; 151 (7): 703-714. PubMed | Google Scholar

  5. Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J Clinical Oncol. 2001; 19: 18-27. PubMed | Google Scholar

  6. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast. 2000 Oct;9(5): 267-70. PubMed | Google Scholar

  7. Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M et al. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat. 2010; 120 (1): 149-160. PubMed | Google Scholar

  8. Pentamwa P, Oanh NT. Levels of pesticides and polychlorinated biphenyls in selected homes in the Bangkok metropolitan region, Thailand. Ann N Y Acad Sci. 2008 ; 1140 : 91-112. PubMed | Google Scholar

  9. Institut National de la Statistique /Direction des Statistiques Economiques. Situation Economique au 1er janvier 2010. INSTAT Antananarivo. 2010. PubMed | Google Scholar

  10. Razafimanjato JY, Randriamanjakasoa JH, Razanadrasara J, Rafaralahy RV. Recensement Général de la Population et de l'Habitat. Institut National de la Statistique, Antananarivo. 1997. PubMed | Google Scholar

  11. McGuire WL, Horwitz KB, Pearson OH and Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer. 1977; 39 (6): 2934-2947. PubMed | Google Scholar

  12. Li CI, Malone KE and Daling JR. Differences in Breast Cancer Hormone Receptor Status and Histology by Race and Ethnicity among Women 50 Years of age and older. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):601-7. PubMed | Google Scholar

  13. Dontu G, El-Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab. 2004; 15 (5): 193-197. PubMed | Google Scholar

  14. EBCTCG (Early Breast Cancer Trialists' Collaborative Group). Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet. 1998 Sep 19;352(9132):930-42. PubMed | Google Scholar

  15. Saglier J, Beuzeboc P, Pommeyrol A et Toledano A. Cancer du sein. Questions et réponses au quotidien. Elsevier Masson, Paris, 2009. PubMed | Google Scholar

  16. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, and Morales AR. Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered Experience with 5,993 Breast Cancers. Am J Clin Pathol. 2005; 123(1): 21-27. PubMed | Google Scholar

  17. Olivotto IA, Truong PT, Speers CH, et al. Time to stop progesterone receptor testing in breast cancer management. J Clin Oncol. 2004 May 1; 2004; 22(9): 1769-1770. PubMed | Google Scholar